FMT
CNST

First Mercantile Trust’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

First Mercantile Trust’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,952
Closed -$69K – 913
2021
Q1 		$69K Sell
2,952
-258
-8% -$7.82K 0.01% 745
2020
Q4 		$92K Sell
3,210
-582
-15% -$14.7K 0.01% 705
2020
Q3 		$87K Buy
3,792
+721
+23% +$17.6K 0.01% 710
2020
Q2 		$92K Buy
+3,071
New +$111K 0.01% 697

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Mercantile Trust's CNST Position: Q2 2021 in Review

First Mercantile Trust sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 2,952 shares — an estimated $69K sold.

First Mercantile Trust first reported a position in CNST in Q2 2020 and held it in 4 quarters. The position peaked at $92K in Q4 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • First Mercantile Trust reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • First Mercantile Trust sold 2,952 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $69K.
  • First Mercantile Trust first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 4 quarters.
  • First Mercantile Trust's Constellation Pharmaceuticals, Inc. position peaked at $92K in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on First Mercantile Trust's 13F filing for Q2 2021, filed 10 Aug 2021.